Whilst berberine is generally considered safe when used appropriately, it is not without potential adverse effects and important safety considerations
Genetic fusion to albumin improves the pharmacokinetic properties of factor IX
The WHO noted that its future guidelines will focus on how to identify and prioritize individuals with the greatest need
PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways
To stay ahead of this shifting environment, pharma companies should consider the following imperatives: Massive patient drop-off undermines obesity GLP-1 uptake: Despite strong demand, only 10% of obesity patients persist with therapy after one year
Liraglutide (Saxenda) is also effective, with patients losing an average of 8% of their body weight over 56 weeks